Table 1.
Parameters | Univariate analysis, HR (95% CI)* |
P | Multivariate analysis, HR (95% CI) |
P value |
---|---|---|---|---|
T stage | ||||
T3-T4 vs. T1-T2 | 1.52 (1.03–2.25) | 0.035 | 1.43 (1.01–2.02) | 0.043 |
N stage | ||||
N1 vs. N0 | 1.53 (1.09–2.15) | 0.013 | 1.32 (1.05–1.66) | 0.019 |
Tumor grade | ||||
G3 vs. G1 + G2 | 1.19 (0.68–2.09) | 0.544 | ||
Tumor size, cm | ||||
≥ 4 vs.<4 | 1.29 (0.93–1.80) | 0.133 | 1.28 (0.92–1.80) | 0.145 |
Vascular invasion | ||||
Yes vs. No | 0.98 (0.68–1.38) | 0.852 | ||
Adjuvant therapy | ||||
Yes vs. No | 0.63 (0.44–0.90) | 0.012 | 0.75 (0.58–0.98) | 0.032 |
Neural invasion | ||||
Yes vs. No | 1.21 (1.01–1.45) | 0.041 | 1.26 (1.01–1.57) | 0.038 |
YAP1 staining | ||||
High vs. Low, | 1.67 (1.18–2.36) | 0.004 | 1.51 (1.04–2.20) | 0.033 |
NOTE: HR hazard ratio, CI confidence interval
Tumor classification and stage were referred to the 7th edition of UICC on cancer staging system. Bold indicates significance